EUVIMEDEUVIMED entdecken
Crossref

Levodopa and dopamine agonist phobia in Parkinson’s Disease — does it really matter? A survey on treatment patterns in Polish tertiary centres

Jakub Kasprzak iD, Jarosław Dulski, Filip Przytuła, Dariusz Koziorowski, Magdalena Kwaśniak-Butowska, Witold Sołtan, Anna Roszmann, Katarzyna Śmiłowska, Michał Schinwelski, Jarosław Sławek

Neurologia i Neurochirurgia Polska · 2025

DOI: 10.5603/pjnns.103168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurologia i Neurochirurgia Polska, 2025. Verfasst von Jakub Kasprzak und 9 weiteren Autor:innen. Beteiligte Einrichtung: Neurology and Stroke Department, St. Adalbert Hospital, Copernicus PL Ltd., Gdańsk, Poland. Hauptthemen laut MEDLINE: Parkinson Disease, Levodopa, Dopamine Agonists, Antiparkinson Agents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseLevodopaDopamine AgonistsAntiparkinson AgentsPractice Patterns, Physicians'HumansPolandMaleFemaleMiddle AgedAgedTertiary Care CentersCarbidopaSurveys and Questionnaires

Stichwörter der Autor:innen

Parkinson’s Diseasedopamine agonist phobialevodopa phobiaprescription patterns

Substanzen

LevodopaDopamine AgonistsAntiparkinson AgentsCarbidopa

Autor:innen und Institutionen

  • Neurology and Stroke Department, St. Adalbert Hospital, Copernicus PL Ltd., Gdańsk, Poland.
  • Division of Neurological and Psychiatric Nursing, Faculty of Health Sciences, Medical University of Gdansk, Gdansk, Poland.
  • Neurology and Stroke Department, St. Adalbert Hospital, Copernicus PL Ltd., Gdańsk, Poland. jaroslaw.dulski@gumed.edu.pl.
  • Division of Neurological and Psychiatric Nursing, Faculty of Health Sciences, Medical University of Gdansk, Gdansk, Poland. jaroslaw.dulski@gumed.edu.pl.
  • Department of Neurology, Mayo Clinic Florida, Jacksonville, Florida, United States. jaroslaw.dulski@gumed.edu.pl.
  • Neurology Department, Faculty of Health Sciences, Brodno Hospital, Warsaw, Poland.

ORCID-Profile: Jakub Kasprzak

Zitieren

APA

Kasprzak, J., Dulski, J., Przytuła, F., Koziorowski, D., Kwaśniak-Butowska, M., Sołtan, W., Roszmann, A., Śmiłowska, K., Schinwelski, M., & Sławek, J. (2025). Levodopa and dopamine agonist phobia in Parkinson’s Disease — does it really matter? A survey on treatment patterns in Polish tertiary centres. Neurologia i Neurochirurgia Polska. https://doi.org/10.5603/pjnns.103168

Vancouver

Kasprzak J, Dulski J, Przytuła F, Koziorowski D, Kwaśniak-Butowska M, Sołtan W, et al. Levodopa and dopamine agonist phobia in Parkinson’s Disease — does it really matter? A survey on treatment patterns in Polish tertiary centres. Neurologia i Neurochirurgia Polska. 2025. doi:10.5603/pjnns.103168

BibTeX
@article{Kasprzak2025,
  author = {Kasprzak, Jakub and Dulski, Jarosław and Przytuła, Filip and Koziorowski, Dariusz and Kwaśniak-Butowska, Magdalena and Sołtan, Witold and Roszmann, Anna and Śmiłowska, Katarzyna and Schinwelski, Michał and Sławek, Jarosław},
  title = {Levodopa and dopamine agonist phobia in Parkinson’s Disease — does it really matter? A survey on treatment patterns in Polish tertiary centres},
  journal = {Neurologia i Neurochirurgia Polska},
  year = {2025},
  doi = {10.5603/pjnns.103168}
}
Kostenlos starten →